Actinomycetoma by Cellulosimicrobium cellulans in a Young Man from Guinea-Bissau: Short Literature Review Regarding a Case Report

Authors

  • Margarida Trindade Torres Serviço de Doenças Infeciosas. Hospital de Curry Cabral. Lisboa. https://orcid.org/0000-0002-5883-0723
  • Beatriz Sousa Nunes Serviço de Infeciologia Pediátrica. Hospital de Dona Estefânia. Lisboa.
  • Luís Varandas Serviço de Infeciologia Pediátrica. Hospital de Dona Estefânia. Lisboa; NOVA Medical School. Faculdade de Ciências Médicas. Lisboa; Instituto de Higiene e Medicina Tropical. Lisboa.
  • Fernando Maltez Serviço de Doenças Infeciosas. Hospital de Curry Cabral. Lisboa.

DOI:

https://doi.org/10.20344/amp.17356

Keywords:

Actinomycetales, Mycetoma/diagnosis, Mycetoma/therapy

Abstract

Mycetoma is caused by the subcutaneous inoculation of filamentous fungi or aerobic filamentous bacteria. Cellulosimicrobium cellulans is a gram-positive bacterium from the order Actinomycetales that rarely causes human disease. The diagnosis is based on the clinical presentation and identification of the causative microorganism. We present a short literature review regarding the case report of a young man diagnosed with actinomycetoma due to Cellulosimicrobium cellulans and who received treatment with an association of amikacin and sulfamethoxazole/ trimethoprim (Welsh regimen).

Downloads

Download data is not yet available.

References

Emery D, Denning DW. The global distribution of actinomycetoma and eumycetoma. PLoS Negl Trop Dis. 2020;14:1-13. DOI: https://doi.org/10.1371/journal.pntd.0008397

Zijlstra EE, van de Sande WW, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 2016;16:100-12. DOI: https://doi.org/10.1016/S1473-3099(15)00359-X

van de Sande WW. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7:1-11. DOI: https://doi.org/10.1371/journal.pntd.0002550

Emmanuel P, Dumre SP, John S, Karbwang J, Hirayama K. Mycetoma: a clinical dilemma in resource limited settings. Ann Clin Microbiol Antimicrob. 2018;17:1-10. DOI: https://doi.org/10.1186/s12941-018-0287-4

Fatahi-bafghi M. Nocardiosis from 1888 to 2017. Microb Pathog. 2017;114:169-84. DOI: https://doi.org/10.1016/j.micpath.2017.11.012

Rivero M, Alonso J, Ramón MF, Gonzalez N, Pozo A, Marín I, et al. Infections due to cellulosimicrobium species: case report and literature review. BMC Infect Dis. 2019;19:1-9. DOI: https://doi.org/10.1186/s12879-019-4440-2

Duane RH. Agents of mycetoma. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas and Bennett’s principles and practice of infectious diseases. 9th ed. Philadelphia: Elsevier; 2020. p.3141-5.e1.

Ramachandra BV, Nayar AS, Subhashini, Chennamsetty K. Mycetoma caused by madurella mycetomatis. Lancet Infect Dis. 2013;2:305. DOI: https://doi.org/10.4103/2277-8632.122183

World Health Organization. Results of the 2017 global WHO survey on yaws. Wkly Epidemiol Rec. 2017;93:417-22.

Fahal A, Mahgoub ES, Mohamed A, Abdel-Rahman ME, Alshambaty Y, Hashim A, et al. A new model for management of mycetoma in the Sudan. PLoS Negl Trop Dis. 2014;8:1-12. DOI: https://doi.org/10.1371/journal.pntd.0003271

Welsh O, Vera-Cabrera L, Welsh E, Salinas MC. Actinomycetoma and advances in its treatment. Clin Dermatol. 2012;30:372-81. DOI: https://doi.org/10.1016/j.clindermatol.2011.06.027

Arenas R, Fernandez Martinez RF, Torres-Guerrero E, Garcia C. Actinomycetoma: an update on diagnosis and treatment. Cutis. 2017;99:E11-5.

Garza JA, Welsh O, Cuéllar-Barboza A, Suarez-Sánchez K, de la Cruz-Valadez E, Cruz-Gomez L, et al. Clinical characteristics and treatment of actinomycetoma in northeast Mexico: a case series. PLoS Negl Trop Dis. 2020;14:1-14. DOI: https://doi.org/10.1371/journal.pntd.0008123

Hay RJ. Subcutaneous mycoses: general principles. In: Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP, editors. Hunter’s Tropical Medicine and emerging infectious disease. 10th ed. Philadelphia: Elsevier; 2020. p.653-8.

Salim AO, Mwita CC, Gwer S. Treatment of madura foot: a systematic review. JBI Database Syst Rev Implement Rep. 2018;16:1519-36. DOI: https://doi.org/10.11124/JBISRIR-2017-003433

Agarwal P, Jagati A, Rathod SP, Kalra K, Patel S, Chaudhari M. Clinical features of mycetoma and the appropriate treatment options. Res Rep Trop Med. 2021;12:173-9. DOI: https://doi.org/10.2147/RRTM.S282266

Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol. 2019;44:123-9. DOI: https://doi.org/10.1111/ced.13642

Shamy ME, Fahal AH, Shakir MY, Homeida MM. New MRI grading system for the diagnosis and management of mycetoma. Trans R Soc Trop Med Hyg. 2012;106:738-42. DOI: https://doi.org/10.1016/j.trstmh.2012.08.009

Laohawiriyakamol T, Tanutit P, Kanjanapradit K, Hongsakul K, Ehara S. The “dot-in-circle” sign in musculoskeletal mycetoma on magnetic resonance imaging and ultrasonography. Springerplus. 2014;3:1-7. DOI: https://doi.org/10.1186/2193-1801-3-671

Fahal AH. Evidence-based guidelines for the management of mycetoma patients. Mycetoma Research Center. Khartoum: University of Khartoum; 2002.

Published

2023-03-15

How to Cite

1.
Trindade Torres M, Sousa Nunes B, Varandas L, Maltez F. Actinomycetoma by Cellulosimicrobium cellulans in a Young Man from Guinea-Bissau: Short Literature Review Regarding a Case Report. Acta Med Port [Internet]. 2023 Mar. 15 [cited 2024 Feb. 21];37(1):46-50. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/17356

Issue

Section

Case Report